Home Medical field Artificial intelligence in personalized medicine, advances in genomic sequencing, the organogenesis of the human brain, building trust with patients, guiding patient decisions through mass spectrometry and much more at explore at the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exhibition

Artificial intelligence in personalized medicine, advances in genomic sequencing, the organogenesis of the human brain, building trust with patients, guiding patient decisions through mass spectrometry and much more at explore at the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exhibition

0

CHICAGO, July 24, 2022 /PRNewswire/ — At the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Expo, laboratory medicine experts will showcase cutting-edge research and technology that is revolutionizing clinical testing and patient care. Of July 24-28 in Chicago, the more than 250 sessions of the meeting will provide information on a wide range of current health topics. Highlights include discussions exploring the use of artificial intelligence (AI) in personalized medicine, advances in multiplexed genomic sequencing and imaging, real-world applications of human brain organogenesis, how to building trust with patients and guiding clinical decisions with mass spectrometry.

AI in personalized medicine. Precision medicine is about tailoring treatments to each patient, and clinicians are increasingly using AI in their clinical prediction models to do this. In the opening speech of the meeting, Dr. Lucila Ohno MachadoVice Dean of Computing and Technology at the University University of California San Diegowill present how AI models are developed, tested, and validated as well as performance metrics that can help clinicians select these models for routine use.

Multiplexed genomic sequencing and imaging. Thanks to advances in multiplexed genomic sequencing and imaging, we can identify small but crucial differences in DNA, RNA, proteins, and more. These techniques have also undergone a 50 million times cost reduction and comparable quality improvements since their appearance. Despite this, healthcare is only just beginning to catch up with the implications of these technologies. dr. St. George’s Churchwinner of the 2022 AACC Wallace H. Coulter Lectureship and Founding Senior Professor and Head of the Wyss Institute for Synthetic Biology at Harvard Universitywill discuss the advances and implications of multiplex technologies in this plenary session.

Applications of human brain organoid technology. The human brain is a very complex biological system and is susceptible to several neurological and neurodegenerative disorders that affect millions of people worldwide. During this plenary session, Dr. Alysson R. Muotri, professor of cellular and molecular medicine at the University University of California San Diego School of Medicine, will explore the concept of human brain organogenesis, or how to recreate the human brain in a dish. Several applications of this technology in neurological care will be discussed.

Building trust in health care. The world is experiencing a crisis of confidence that is affecting the delivery of healthcare across the globe. dr. Thomas Lee, Chief Medical Officer of Press Ganey Associates and Professor of Health Policy and Management at Harvard TH Chan School of Public Health, will describe the importance of building trust between patients and healthcare workers in this plenary session. . It will explore a three-component model for building trust and the types of interventions most likely to be effective.

Guide clinical decisions with mass spectrometry. In this, the closing speech of the meeting, Dr. Livia Schiavinato Eberlinlecturer in surgery and director of translational research and innovations at Baylor College of Medicine, will discuss the development and application of direct mass spectrometry techniques used in clinical microbiology laboratories, clinical pathology laboratories, and the operating room. The presentation will focus on results obtained in ongoing clinical studies using two direct mass spectrometry techniques, desorption electrospray ionization mass spectrometry imaging and MasSpec Pen technology.

Additionally, at the Clinical Lab Expo, more than 750 exhibitors will showcase innovative technologies that are just coming to market in every clinical laboratory discipline.

“The ability of laboratory medicine to adapt to changing health conditions and to use the scientific knowledge of the field to improve the quality of life is unprecedented. This ability is constantly increasing, with diagnostic technologies emerging every day in fields as diverse as mass spectrometry, artificial intelligence, genomic sequencing and neurology,” said the CEO of AACC Mark J. Golden. “The 2022 AACC Annual Scientific Meeting will highlight the pioneers in laboratory medicine who are harnessing these new advances to improve patient care.”

Session Information

Registration for the AACC Annual Scientific Meeting is free for members of the media. Journalists can register online here: https://www.xpressreg.net/register/aacc0722/media/landing.asp

AI in personalized medicine

Session 11001 Biomedical informatics strategies to improve individualized predictive models
Sunday July 24
5:00 p.m. to 6:30 p.m. U.S. Central Time

Multiplexed genomic sequencing and imaging

Session 12001 Multiplexed and exponential improvement technologies
Monday July 25
8:45 a.m. – 10:15 a.m. Central US Time

Applications of human brain organoid technology

Session 13001 Applications of human brain organoid technology
tuesday july 26
8:45 a.m. – 10:15 a.m. Central US Time

Building trust in health care

Session 14001 Building Trust in Troubled Times
Wednesday July 27
8:45 a.m. – 10:15 a.m. Central US Time

Guide clinical decisions with mass spectrometry

Session 15001 Guiding clinical decisions with molecular information provided by direct mass spectrometry technologies
Thursday July 28
8:45 a.m. – 10:15 a.m. Central US Time

All sessions will take place in room S100 of the McCormick Place Convention Center at Chicago.

About AACC Annual Scientific Meeting and Clinical Laboratory Exhibition 2022
The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about the exciting science of July 24-28. Plenary sessions will explore clinical prediction models based on artificial intelligence, advances in multiplex technologies, the organogenesis of the human brain, building trust between the public and health experts, and spectrometry techniques of direct mass.

At the AACC Clinical Lab Expo, more than 750 exhibitors will occupy the show floor of the McCormick Place Convention Center in Chicago with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point-of-care and l ‘automating.

About the AACC
Dedicated to improving health through laboratory medicine, AACC brings together more than 70,000 clinical laboratory professionals, physicians, researchers and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, laboratory management and other areas of laboratory science is progressing. Since 1948, the AACC has worked to advance common interests in the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

Christine DeLong
AACC
Senior Manager, Communications and Public Relations
(p) 202.835.8722
[email protected]

Molly Pollen
AACC
Senior Director, Communications and Public Relations
(p) 202.420.7612
(c) 703.598.0472
[email protected]

SOURCE AACC